118 related articles for article (PubMed ID: 21563997)
1. Relief of vaginal discomfort - hormones or water?
Thompson E
Climacteric; 2011 Jun; 14(3):398-9; author reply 399. PubMed ID: 21563997
[No Abstract] [Full Text] [Related]
2. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and its effect on vaginal atrophy in post-menopausal women.
Kelley C
Urol Nurs; 2007 Feb; 27(1):40-5. PubMed ID: 17390926
[TBL] [Abstract][Full Text] [Related]
4. Conjugated estrogens (Premarin) vaginal cream.
Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
[TBL] [Abstract][Full Text] [Related]
5. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
[No Abstract] [Full Text] [Related]
6. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.
Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H
Menopause; 2009; 16(4):735-41. PubMed ID: 19252451
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
Simon JA; Maamari RV
Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
[TBL] [Abstract][Full Text] [Related]
8. Atrophic vaginitis.
Stika CS
Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
[TBL] [Abstract][Full Text] [Related]
9. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
[TBL] [Abstract][Full Text] [Related]
10. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.
Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
Post Reprod Health; 2015 Sep; 21(3):88-97. PubMed ID: 25995333
[TBL] [Abstract][Full Text] [Related]
11. Effect of raloxifene on sexual function in postmenopausal women.
Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
[TBL] [Abstract][Full Text] [Related]
12. Management of postmenopausal vaginal symptoms in women.
Bond S; Horton LS
J Gerontol Nurs; 2010 Jul; 36(7):3-7. PubMed ID: 20608584
[TBL] [Abstract][Full Text] [Related]
13. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
Serati M; Bogani G; Di Dedda MC; Braghiroli A; Uccella S; Cromi A; Ghezzi F
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
[TBL] [Abstract][Full Text] [Related]
14. Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners.
Simon JA; Nappi RE; Kingsberg SA; Maamari R; Brown V
Menopause; 2014 Feb; 21(2):137-42. PubMed ID: 23736862
[TBL] [Abstract][Full Text] [Related]
15. An overview of chronic vaginal atrophy and options for symptom management.
Woods NF
Nurs Womens Health; 2012 Dec; 16(6):482-93; quiz 494. PubMed ID: 23253575
[TBL] [Abstract][Full Text] [Related]
16. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
17. An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.
Dizavandi FR; Ghazanfarpour M; Roozbeh N; Kargarfard L; Khadivzadeh T; Dashti S
Post Reprod Health; 2019 Mar; 25(1):11-20. PubMed ID: 30786797
[TBL] [Abstract][Full Text] [Related]
18. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
19. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
20. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
